This content is machine translated Atherosclerosis Is there a need for new lipid-lowering drugs in the era of PCSK9 inhibitors? Recent progress Cardiovascular disease (CVD) remains the leading cause of death worldwide. Recent guidelines on HKE prevention highlight the extent to which elevated low-density lipoprotein cholesterol (LDL-C) is one of the most… CME-Test
View Post 4 min This content is machine translated Management of dyslipidemia Lipid-lowering agents for secondary prophylaxis also effective in elderly patients A recent meta-analysis published in the Lancet concluded that lipid lowering achieved comparable reductions in cardiovascular events in people over 75 years of age as in younger individuals. In elderly…
